Clinical Trial 46002

Fort Lauderdale, FL 33073


Phase 4 study where patient has severe dry eyes that is not controlled by Cyclosporine (0.05%) (Restasis). Subject enrollment will be classified by evidence of DED. Solution will be used to treat the patient (Cequa), in eahc eye twice a day for twelve weeks. Cequa is expected to show improved benefits and reduction of severe dry eye disease.


1. Must be 18

2. Must provide written consent 

3. Must have a history of clinical diagnosis of DED

4. Must have a total CSF score of over 6 

5. Must have a BCVA at 20/200 or better in both eyes

6. Must be willing to discontinue use of all dry eye therapy 

7. Women of childbearing potential must have a negative urine pregnancy test 

8. Must agree to use contraception 

Qualified Participants May Receive:

1. Financial compensation TBD

2. Information about other studies and treatment for dry eyes 

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.